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Abstract
The revolution in cardiac care over the past two decades, characterized by emergent
revascularization, drug eluting stents, anti-platelet medications, and advanced imaging has had
little impact on overall ACS recurrence, or ACS prevention. The “Perfect Storm” refers to a
confluence of events and processes, including atherosclerotic plaque, coronary flow dynamics,
hemostatic and fibrinolytic function, metabolic and inflammatory conditions, neurohormonal
dysregulation, and environmental events that give rise to, and result in an ACS event. In this
article we illustrate the limits of the traditional main effect research model, giving a brief
description of the current state of knowledge regarding the development of atherosclerotic plaque
and the rupturing of these plaques that defines an ACS event. We then apply the Perfect Storm
conceptualization to describe a program of research concerning a psychosocial vulnerability factor
that contributes to increased risk of recurrent ACS and early mortality, and that has defied our
efforts to identify underlying pathophysiology and successfully mount efforts to fully mitigate this
risk.
There is a “Perfect Storm” coming. Although this metaphor has been used to warn us about
the ongoing U.S. fiscal crisis and about impending weather events, it is also a potentially
useful metaphor when applied to the occurrence of an acute coronary syndrome (ACS).1,2
The “Perfect Storm” as a conceptual model applied to ACS proposes to us that ACS events
are not caused by the presence of a single, or even a number of specific coronary heart
disease (CHD) risk factors, but rather results from an unfortunate confluence involving any
of several stable underlying CHD vulnerability factors and the co-occurrence of any of
several situational or environmental events that acutely activate critical physiological
processes, thereby contributing overall to a period of increased risk.3 Thus the “Perfect”
ACS storm is defined as the joint presence of many co-occurring pathophysiologic processes
that lead to a clinical event. This Perfect Storm will happen for more than 1 million
American adults each year. Many of these individuals will join the more than 17 million
living American adults who have survived an ACS but continue to suffer from the
cardiovascular damage remaining after the ACS event.4 Understanding how the Perfect
Storm model aids in the investigation of this large public health problem is an exciting
© 2013 Elsevier Inc. All rights reserved.
Correspondence should be addressed to: Karina W. Davidson, Center for Behavioral Cardiovascular Health, Department of Medicine,
Columbia University Medical Center, PH9, Room 9-319, 622 W. 168th Street, New York, NY 10032, kd2124@columbia.edu.
Conflict of interest statement: None to report
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
Prog Cardiovasc Dis. Author manuscript; available in PMC 2014 May 01.
Published in final edited form as:













venture that may provide new insights into how to prevent ACS, and into the management
of CHD for those already suffering from the physiological consequences of an ACS.
The Perfect Storm Metaphor and Psychosocial Risk Factors
In this article we apply the Perfect Storm framework to the study of psychosocial risk for
cardiovascular disease. We start by illustrating the limits of the traditional research strategy
that identifies a risk factor in isolation and by giving a brief description of the current state
of knowledge regarding the development of CHD and the vulnerable plaque concept that
underlies the presentation of an ACS event. We then consider how a research agenda within
a Perfect Storm framework would differ from the traditional approach that has guided
investigation and contributed to our understanding of ACS to date. We use this as an
impetus to then describe the application of the Perfect Storm conceptualization in the
development of a program of research concerning a psychosocial vulnerability factor that
contributes to increased risk of recurrent ACS and early mortality, and that has defied our
efforts to identify underlying pathophysiology and successfully mount efforts to fully
mitigate this risk.
Coronary Atherosclerosis and ACS—A View of the Traditional Research
Strategy
There continues to be a revolution in cardiac care that began two decades ago. This
revolution is epitomized by the emergence of new intervention and imaging technologies
that have improved cardiac mortality outcomes substantially, at least for those patients who
present with ST-elevation myocardial infarction. Yet they have had little impact on overall
ACS recurrence, 5,6 nor have they improved our ability to prevent ACS.
Coronary atherosclerosis is a progressive disease that initiates as early as the childhood and
adolescent years, and depending on a range of genetic, behavioral, and environmental
factors, progresses into adulthood, such that upwards of 80% of middle-aged adults in
developed nations have evidence of coronary artery disease (CAD). Yet the annual
incidence of ACS in the United States for people over age 40 is less than 1%.7 Thus, merely
the presence of CAD is not sufficient for ACS and other factors must be involved. Research
efforts have therefore been directed at identifying the factors that lead from the development
and progression of atherosclerotic plaque in the coronary arteries to the catastrophic rupture
of these plaques and the occurrence of ACS. As this research has progressed it has become
apparent that, 1) most ACS events are caused by plaque disruption with subsequent
occlusive platelet-thrombus formation, but 2) the converse is not true – e.g., most disrupted
coronary plaques with platelet-thrombus formation do not lead to ACS event onset.8
Pathology and clinical studies have shown that plaque rupture and non-occlusive thrombus
formation are frequently present in the absence of clinical ACS symptoms. Therefore, an
ACS event is not a necessary consequence of coronary plaque disruption, and while plaque
disruption may be a necessary cause of ACS, it is by no means sufficient.
Plaque Rupture and Thrombosis, and the Search for the Vulnerable Plaque
Today, research continues to focus on the factors that will help practitioners identify the
vulnerable plaque before it ruptures, so as to prevent ACS. Factors such as morphology and
genetics, have been most frequently studied in isolation. Researchers have thus given less
consideration – for example - to the properties of blood that underlie the thrombosis
precipitated by plaque rupture, the properties of coronary vasculature that support or resist
thrombus formation, or any of several other features of the individual that might be
implicated in the complex cascade that defines an ACS event. This type of investigation is
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sometimes referred to by methodologists as a ‘main effects’ model. This approach to science
implicitly assumes that the one factor under investigation—in this case plaque vulnerability
— is both necessary and sufficient to cause the outcome — an ACS event. This
“reductionist disease model”9 has taken the methodological tact of dissecting systems into
their constituent parts, and it has been very effective in providing insight into many
biological and chemical components of living processes.10 This approach has however,
reached its limit. Biological systems are exceedingly complex and have emergent properties
that cannot be explained, or even predicted, by studying their individual parts.10 While this
simplifying methodological approach has proven invaluable in many human disease areas –
including CHD - it can lead to oversimplifications that limit investigation, understanding,
and the development of new treatments.
The Perfect Storm Conceptual Model: Implications for CHD Classic Risk
Factors and Pathophysiologic Processes
Recently, Arbab-Zadeh and colleagues3 in an elegant review of the pathophysiology
underlying ACS events, used the term “Perfect Storm” to describe the confluence of events
and processes that give rise to, and result in an ACS (see Table 1). The factors they list that
are associated with increased ACS event risk are categorized according to characteristics of
atherosclerotic plaque (e.g., endothelial dysfunction, plaque composition/location/burden/
configuration,); coronary flow dynamics (e.g., blood viscosity, shear stress, vascular tone/
reactivity); instrinsic hemostatic and fibrinolytic function (e.g., platelet function); metabolic
and inflammatory conditions (e.g., diabetes, obesity); neurohormonal dysregulation (e.g.,
depression, catecholamine surge, autonomic dysfunction); and environmental factors and
triggers (e.g., stress). While they state that it remains to be fully determined whether a
particular factor plays a role specifically in the development and progression of
atherosclerosis, in the frequency of plaque alterations, or in the promotion of thrombotic
vascular occlusion, they emphasize that it may be a combination of these effects that
underlies their linkage to ACS risk. Similarly, it is understood that many of these factors
serve to influence others. For example, psychological stress will dynamically influence
autonomic function, resulting in an increase in sympathetic activity, as evidenced by a
catecholamine surge. This will in turn increase shear stress within the coronary circulation,
particularly at arterial branching points, which are often the site of atherosclerotic lesions.
Lastly, since many of these factors evidence a circadian variability, “timing” may be an
essential ingredient of the Perfect Storm. Thus, the catecholamine surge that is typically seen
in the early part of the day may serve as an ACS trigger, depending on the plaque, vascular,
and platelet conditions that by happenstance are co-occurring at that time on a given day.
Yet, on a preceding day or a subsequent day, the conditions of the vasculature, plaque, and/
or blood may not be sufficient for an ACS, given the absence of that catecholamine surge.
Similarly, factors such as exposure to pollutants (e.g., tobacco smoke) or stress, or post
prandial effects, can influence ACS risk throughout a given day, by impacting on several
factors including endothelial function, but again also depending on the transient conditions
of several other critical aspects of the Perfect Storm.
The complexity of the various factors and their inter-relationship in the progression from
coronary atherosclerosis to ACS leads the authors to state that, “one may establish certain
probabilities for plaque rupture/erosion and occlusive thrombus-favorable conditions to
coincide, but a substantial residual component of uncertainty will remain”. While this may
be somewhat disheartening to those who share an interest in a future defined by a
substantially reduced universal ACS risk, all is not lost. The Perfect Storm concept provides
a potentially highly useful framework within which to articulate testable hypotheses that
begin to include the wide array of pathophysiological processes underlying and contributing
to atherosclerosis and ACS risk. Indeed, this conceptualization may be a critical basis for
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planning and executing future research studies that will provide greater insights into the
ACS phenomenon. An approach such as this could contribute to the development and testing
of improved primary and secondary prevention strategies that do not rely on an overly
simplistic “main effects model”, and thereby result in better overall patient management. In
the next Section we demonstrate the utilization of this model in the articulation of a research
program focusing on the confluence of two Perfect Storm factors – depression and exposure
to acute stress- that each contribute significantly and independently to ACS recurrence and
mortality risk, and that when present together, may better aid our investigation of the
underlying pathophysiology of their ACS recurrence risk.
Depression and Risk of Recurrent ACS and Mortality
As reviewed in greater detail elsewhere in this volume, epidemiological studies have
demonstrated convincingly that ACS patients with depression are at greater risk for ACS
recurrence and mortality compared to their non-depressed counterparts.11–14 The hazard
ratio associated with depressive symptoms is 1.80 (95% CI: 1.46–2.51) for all-cause
mortality,15 and 1.95 (95% CI: 1.33–2.85) for myocardial infarction (MI) recurrence.16 A
recent meta-analysis shows that depressive symptoms continue to strongly identify ACS
patients at mortality risk [relative risk: 3.41 (95% CI: 2.19–5.31.15 Depressive symptoms are
on par with more conventional ACS recurrence prognostic factors for predicting death and
ACS recurrence. This risk continues to be observed in the most recent studies and meta-
analyses, despite the continual improvement in cardiology interventions, medications, and
care.17–21
Depression and Post-ACS Recurrence/Mortality Risk: Mechanism(s) of
Action
Many biological and behavioral mechanisms may underlie the depression—ACS recurrence
and mortality link, and a number of these have been examined systematically.22 Proposed
biological mechanisms include greater risk of arrhythmogenesis – in part due to alterations
in autonomic regulation23,24 and25,26 impaired coronary flow reserve and associated vascular
factors that increase risk of myocardial ischemia.27,28 Proposed behavioral mechanisms
include adherence to prescribed medications29,30 and engagement in secondary prevention
behavioral recommendations such as avoiding a sedentary lifestyle and receiving sufficient
sleep.31 Inconsistent findings have been reported for each of these proposed mechanisms,
however.15 Thus, while it is now widely accepted that depressive symptoms after ACS
predict poorer medical prognosis, there remains a gap in our knowledge about which of
these proposed mechanisms best account for this association. Without this knowledge, we
cannot adequately target mechanisms in clinical trials so as to reduce this risk.
Depression and Post-ACS Recurrence/Mortality Risk: A Perfect Storm?
Most research on depression related post-ACS recurrence and mortality risk has been
conducted with an implicit “main effects model” of how causal mechanism(s) responsible
for this risk would operate. This model can be described according to the following three
implicit assumptions: (1) depressive symptoms in ACS patients would directly disrupt the
proposed mechanism at all times; (2) the presence of some additional Perfect Storm factor
would not be required to reveal the presence of the disrupted mechanism, and (3) the
presence of some additional Perfect Storm factor would not differentially affect ACS
patients with depressive symptoms compared to those without depressive symptoms. These
three implicit assumptions have led us to use a simple between-subject design, comparing
depressed and nondepressed ACS patients, and looking for differences in the mechanism
that is hypothesized to underlie the depression related risk. When evidence has been
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contradictory, we have assumed that we have not yet identified the responsible
mechanism(s). We propose instead that it is time to abandon the ‘main effects’ approach for
understanding this depression associated risk, and consider the benefits of the more complex
Perfect Storm conceptualization.
Historically, the study of psychosocial vulnerabilities for ACS such as depression, anxiety,
hostility, and post-traumatic stress disorder has also followed the scientific tradition of
employing the ‘main effects’ or reductionist model of science, and have frequently studied
these in isolation of each other, and even in isolation of the classic CHD risk factors.15 Suls
and Bunde pointed out the limits of this approach and suggested that we needed more
complex models of the association of emotion and CHD in order to gain a better
understanding of the role that emotions play in the etiology and course of CHD, and in the
triggering of an ACS.32 Indeed, the consideration of two factors at the same time, such as
the co-occurrence of a chronic angry temperament and getting angry in some specific
situation, may be required to identify emotional factors that result in defibrillator shock-
terminated arrhythmias.33
The Perfect Storm: A Model for a Program of Research
How might we apply the Perfect Storm conceptualization to the study of mechanisms
linking a Perfect Storm factor such as depression to post-ACS recurrence and mortality risk?
We propose a model that, as with the Perfect Storm, describes a confluence of factors to
describe the resulting risk of ACS recurrence and mortality. Within this Model, we test the
effects of a confluence of both depression and acute stress on the activation of four distinct
pathways that have each been observed in relation to depression, and that each have been
linked to post-ACS medical prognosis. These four pathways are, 1) Blood – or
thrombogenicity; 2) Coronary Perfusion – and related vascular factors; 2) Arrhythmia – and
related autonomic factors; and 4) Behavior – broadly including physical activity, medication
adherence, and sleep (see Figure 1). We thus provide a challenge to the traditional efforts
directed toward elucidating the depression related ACS recurrence/mortality risk. Indeed,
just as regional wall abnormalities and myocardial perfusion defects are identified by
echocardiography and myocardial perfusion imaging only under exercise or pharmacologic
stress, and these defects will remain undetected if stress exposure is not utilized, it may be
that we have to ‘stress’ the depressed CHD patient to reveal the mechanisms responsible for
depression related risk.
Depression and Thrombogenicity
Several small case-control studies have demonstrated the existence of platelet
hyperreactivity in apparently healthy, depressed patients,25,26,34 though evidence of
exaggerated platelet reactivity in depressed patients with CAD is limited. Laghrissi-Thode et
al35 described higher platelet factor 4 (PF4) and β-thromboglobulin (BTG), markers of
platelet aggregation, in depressed vs. non-depressed CAD patients. Gehi et al however,
found no association between depression and either PF4 or BTG in CAD patients who were
withdrawn from ASA for 7 days.36 Using pooled data from 3 studies of ACS patients,
Serebruany et al37 found that depressed ACS patients exhibited higher levels of PF4, BTG,
and platelet/endothelial cell adhesion molecule-1 when compared to non-depressed ACS
patients without depression.
There is also evidence that acute psychological stress increases the level of platelet
aggregation. A systematic review by Thrall et al38 concluded that acute psychological stress
is associated with increases in platelet aggregation, and suggested that these increases may
have the potential of triggering ACS events. Several studies have shown that a mental stress
task increases ADP-induced platelet aggregation in apparently healthy individuals and in
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patients with CAD. The data demonstrating an effect of a mental stress task on platelet
aggregation are most consistent with immediate post-task measurements. Some studies have
also shown effects on platelet aggregation at 30 and 60 minutes into recovery after a mental
stress task. Although a few studies have indicated that basal levels of platelet aggregation
are reduced by antiplatelet agents, these agents do not blunt mental stress-induced increases
in platelet aggregation.
After an ACS event, when disrupted coronary plaque(s) are healing, it is plausible that
depressed vs. non-depressed patients are at risk for recurrent MI/mortality because they have
a greater increase in platelet aggregation in response to stress. In depressed patients, an
exaggerated platelet-thrombogenesis response to psychological stress may induce occlusive
thrombus formation leading to another ACS event, thus demonstrating that depression and
stress together may create a Perfect Storm. The testing of this overall scenario – a
comparison of depressed and non-depressed post-ACS patients in their response to
psychological stress, preferably under controlled laboratory conditions, and examination of
changes in key measures of thrombogenicity across resting and stress conditions –
represents one vehicle for implementation of a Perfect Storm conceptualization.
Depression and Coronary Perfusion
Among the “Perfect Storm’s” upstream physiological processes identified as critical to the
expression of an ACS event are endothelial (dys)function and vascular reactivity, as
contributors to perturbations – or dysregulation – in dynamic myocardial blood flow.
Endothelial dysfunction, seen in the earliest stages of CHD, is marked by a paradoxical or
inappropriate vasoconstriction. This also has been observed among otherwise healthy
individuals with depression.39 It has also been observed in response to mental stress among
healthy non-depressed individuals, with blockade of endothelin-1 (ET-1), the most potent
vaso-active protein, mitigating this effect.40 We have also observed that stable CHD patients
with elevated depression symptoms demonstrate a level of ET-1 previously linked to early
recurrent ACS.27
Since the description in the 1970s of myocardial ischemia provoked by mental and
emotional stress,41 research has consistently shown that approximately half of patients with
stable coronary artery disease (CAD) evidence this mental stress provoked myocardial
ischemia (MSI) on myocardial perfusion imaging (see Figure 2) despite optimal medical
management.42 We and others have shown a 2.4–3.0 fold increased independent risk of
myocardial infarction over 1–4 years for patients demonstrating MSI,43–45 and a 3.0 risk
ratio of 5-year mortality.46
The model of CAD that guides disease management focuses on the identification and
mitigation of obstructive atherosclerotic plaque in the large coronary vessels. In contrast to
this traditional model whereby ischemia occurs as a function of a static occlusion in the
large coronary vessels that limit blood flow, mental and emotional stress41 induces temporal
heterogeneity of myocardial perfusion. Yeung et al47 demonstrated that mental stress
provokes a paradoxical epicardial vasoconstriction at the site of both obstructive and non-
obstructive plaques, and a consequent reduction in myocardial blood flow, though whether
this effect was due to epicardial vasoconstriction vs. microvascular dysfunction could not be
ascertained. Using positron emission tomography we observed that during mental stress,
coronary flow reserve (CFR) - the ability of the microvascular bed to dilate in response to
stimulation and thereby augment coronary blood flow according to the needs of myocardial
tissue - was lower in regions served by vessels without significant epicardial stenosis than in
regions served by vessels with significant stenosis. Furthermore, while coronary resistance
fell during mental stress in regions served by vessels with significant stenosis, coronary
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resistance increased in regions served by vessels without significant stenosis.48 This
attenuation in myocardial blood flow during mental stress in regions without significant
stenosis along with the increase in resistance, implicates the coronary microvascular bed in
the pathophysiology of MSI. How might depression further contribute to this apparent
dysregulation?
In one small study, the relationship of depression to MSI risk was tested in a heterogeneous
sample of patients with coronary disease.49 A curvilinear relationship was observed, such
that patients with mild to moderately severe symptoms of depression were at 2 -fold
increased risk of MSI, while those with more severe symptoms of depression were not. The
sample size was relatively small, the measure of depression has not been widely linked to
ACS recurrence/mortality risk, and the marker of ischemia – wall motion abnormality – is
less sensitive/specific than myocardial perfusion.48 Depression, myocardial perfusion, and
coronary flow reserve in response to adenosine has been the focus of one small study28 of
male twin pairs from the Twins Heart Study. Not surprisingly given that the sample was not
selected for having known CAD disease, less than 10% of the sample demonstrated a
significant myocardial perfusion abnormality with pharmacologic stress, and major
depression was not a predictor of this outcome. This study did however, find greater
impairment in CFR in dizygotic twins with a major depression diagnosis vs. their non-
depressed control twins.
Both depression and acute stress are associated with perturbations in vascular processes –
endothelial function, myocardial perfusion, and CFR – that are part of the Perfect Storm
articulated by Arbab-Zadeh and colleagues. As with thrombogenicity, the testing of this
overall scenario – a comparison of depression and non-depressed patients after ACS,
exposure to psychological stress, and examination of effects on regional myocardial
perfusion and coronary flow reserve – represents a second vehicle for implementation of a
Perfect Storm conceptualization.
Depression and Arrhythmogenesis
Most ACS patients present to the emergency department (ED),50 and during their stay it can
often become overcrowded and chaotic.51 Admission to an ED when in the throes of an
ACS is a stressful experience, and when that ED is overcrowded, it is exceedingly
stressful.21,52 ED crowding varies greatly through the course of a single day in most
hospitals throughout the US,17,19,53 and is associated with greater in-hospital17,20 30-day,
and 1-year post-ACS mortality. ACS patients treated during times when the ED is most
crowded are 3 to 5 times more likely to experience subsequent in-hospital MI than those
treated during less crowded times and are at significantly greater subsequent MI/mortality
risk.18
Might the stress of the ED also be arrhythmogenic? From epidemiologic studies it has been
shown that there is an increase in the incidence of sudden death associated with emotionally
devastating disasters such as earthquake and war,54,55 and ventricular arrhythmias, one
possible link between stress and sudden death, increased in the emotional weeks following
the destruction of the World Trade Center in 2001.56 Strong emotion in response to real life
stress can spontaneously trigger ventricular arrhythmias in patients with ICDs,57 and these
arrhythmias are polymorphic,58 suggesting that they are potentially lethal. Further,
psychological stress has been found to facilitate the induction, and increase the rate of
ventricular tachycardia, and makes the termination of these arrhythmias more difficult,
effects that are correlated with increases in circulating levels of epinephrine and
norepinephrine.59 Further, ventricular tachycardia and sudden death occur more frequently
in the morning hours,60 the time of peak catecholamine levels and lowest vagal tone. From
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this research we can see that among the effects of stress are a change in autonomic balance –
greater sympathetic activity as characterized by an increase in circulating catecholamines,
and a reduction in cardiac vagal control as characterized by lower heart rate variability.
As with thrombogenicity and myocardial perfusion, the scenario of stress in the ED has
features that are consistent with the Perfect Storm conceptualization of ACS, and ventricular
arrhythmias during time in the ED might demonstrate this for at risk individuals. How might
this be utilized to understand the contribution of depression to ACS recurrence and mortality
risk? In a secondary analysis of data from a large cohort study of ACS patients, researchers
found that those who report both depression and exposure to high stress were at significantly
greater risk for MI recurrence or mortality. It is also known – as discussed in another article
in this issue – that one feature of depression is autonomic dysregulation, characterized by a
general increase in sympathetic activity and a reduction in cardiac vagal control, a scenario
that could increase risk of ventricular arrhythmia. Thus both depression and acute stress are
associated with the autonomic or neurohormonal effects that are part of the Perfect Storm
articulated by Arbab-Zadeh and colleagues.3 The testing of this overall scenario in an effort
to understand the depression related ACS recurrence and mortality risk could be
accomplished by examining the effects of ED crowding on autonomic indices and incidence
of ventricular arrhythmia, and determining whether depressed ACS patients admitted to the
ED when it is most crowded and stressful evidence greater disruption in autonomic function
and a greater number of ventricular arrhythmias. Such a “naturalistic” undertaking, where
the stress is “real world” and is likely to vary throughout a patient’s ED stay provides an
elegance not otherwise provided for, and represents a third vehicle for implementation of a
Perfect Storm conceptualization.
Depression and Cardiovascular Risk Behaviors
The last decade has been marked by significant improvements in the medical care of patients
with cardiovascular disease, yet behavioral factors continue to account for a substantial
proportion of the risk of MI recurrence and premature mortality. Indeed, behavioral
mechanisms such as sedentary lifestyle may bear greater responsibility for the incidence of
CHD than biological mechanisms.61 Similarly, a failure to adhere to recommended health
behaviors after ACS – including the initiation of an exercise program and the taking of
prescribed medications – contributes substantially to risk for recurrent ACS and early
mortality.30,62–64 In fact, it is estimated that improving health behaviors could reduce CHD
risk and the associated public health burden by up to 40%.65
While it is widely accepted that depressive symptoms after ACS predict poorer medical
prognosis, there remains a gap in our knowledge about the contribution of behavioral
mechanisms to this association, and which of several such mechanisms best explain this
association. Without this knowledge, we cannot adequately target mechanisms to reduce this
risk.
Among potential behavioral mechanisms is medication adherence. It has been shown that in
the weeks after suffering the distress of an ACS, depressed patients have lower medication
adherence compared to non-depressed patients.63,66 Other studies however, have shown no
differences in medication adherence between depressed and non-depressed patients, whether
with67 or without68 comorbid CHD. Yet other studies of medication adherence show it to be
a dynamic behavior that varies over time.69,70 The precise circumstances that contribute to
poorer adherence at one time and better adherence at another time remain to be identified. It
is possible that these inconsistent findings are driven by differences in study design that lead
to different circumstances during which medication adherence was measured.
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Physical activity may be another important behavioral mechanism that accounts for much of
the excess cardiovascular risk associated with depression.71 For example, it is well known
that depressed post-ACS patients attend cardiac rehabilitation less frequently,72 exercise
less,71 and report less physical activity overall, than do non-depressed post-ACS patients.31
Furthermore, in healthy adolescents, reduced physical activity predicts onset of
depression.73 It is currently thought that physical inactivity predisposes one to depression,
and that depression predisposes one to even more physical inactivity, creating a forward
feed cycle that would be particularly harmful for recent ACS patients.74,75 Moreover,
although there is evidence that exercise interventions can be efficacious for treating
depression,76,77 it remains unknown if treating depression by exercise would reduce the
depression-related ACS recurrence and mortality risk.
As described earlier, most research examining behavioral mechanisms of cardiovascular risk
has been conducted with implicit assumptions characterized by a main effects model, such
that if the depression-recurrence/mortality risk could be attributed to behavioral
mechanisms, these mechanisms would always be observed in depressed but not in non-
depressed post-ACS patients, and acute stress would have no differential effect on the
behavioral mechanism. Yet, emerging research now shows that exposure to acute stress
adversely impacts good health behavior practices.78 There is also emerging evidence in non-
CHD patients that stress can be especially deleterious to health behaviors among patients
with underlying depression.79 Depressed patients under acute stress might experience
greater difficulty in self-regulation and thus fail to use cognitive, emotional, or behavioral
resources to achieve desired health behaviour outcomes. This could furthermore increase
their propensity to engage in adverse health behaviors.80
Again, the Perfect Storm conceptualization provides a rich context within which to develop
an innovative research design so as to elucidate the contribution of behavior to the
depression related ACS recurrence and mortality risk. This could be tested by examining the
effects of real life stress on the conduct of specific health behaviors among post-ACS
patients, and determining whether those with vs. without depression are more susceptible to
the effects of stress. As part of standard cardiologic care, patients are often scheduled for
“staged” percutaneous interventions. These events represent an excellent example of a
standardized real life stressor that can be used to test the hypothesis that the confluence of
stress and depression affects a patient’s engagement in critical health behaviors. First, even
though these represent planned rather than emergent procedures, the experience of
undergoing a percutaneous intervention is likely perceived as very stressful by patients as
they require spending a day in the hospital, which markedly disrupts their daily routine
including their diet, sleep schedules, work, and social networks. Patients are also
immediately immersed in an unfamiliar medical system where they receive anesthetics, are
instrumented with needles and intravenous medications, and interact with multiple providers
during the course of their hospitalization. There is also the inherent risk of catastrophic
events associated with the percutaneous procedure, however small that risk may be. Given
that “staged” percutaneous interventions are scheduled for a specific day, it is possible to
monitor key health behaviors such as engagement in exercise and medication adherence in
the weeks before and after the scheduled interventions. This monitoring is easily done
objectively and unobtrusively using accelerometers to measure physical activity and
electronic pill bottles (reviewed elsewhere in this issue) to measure medication adherence,
thereby eliminating the problems inherent in self-report. Patterns of (non) adherence could
then be observed in the days leading up to, and subsequent to the intervention, and the
differential effects of this real life stressor on depressed vs. non-depressed post-ACS patients
thereby determined. As with the three previously described potential biological mechanisms,
the testing of this overall scenario – a comparison of depression and non-depressed patients
after ACS, exposure to real world psychological stress, and examination of effects on critical
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health behaviors, represents a fourth vehicle for implementation of a Perfect Storm
conceptualization.
Summary
Research on the determinants and mechanisms of recurrent ACS in patients with CHD has
been hampered by a myopic focus on single risk factors or sets of risk factors that are
assumed to each act independently. We propose a Perfect Storm conceptual model to
advance an understanding of ASC recurrence within the field of behavioral cardiology. This
framework proposes that the co-occurrence of multiple pathophysiologic and psychosocial
factors, each acting in tandem with one another, offers a superior model by which to
elucidate the risk of recurrent ACS in patients with CHD. We have presented an example of
how the Perfect Storm framework can contribute to a deeper understanding of the
mechanisms underlying the association of depression and risk of recurrent ACS and
mortality by outlining a set of studies that will examine the confluence of depression and
acute stress in the activation of four distinct pathways: thrombogenicity, coronary perfusion,
arrhythmia, and behavior.
The Perfect Storm model has the potential to inform cutting edge programs of research in
other areas of behavioral cardiology and within the field of cardiology more broadly by
addressing the complex, interplay of the multiple processes involved in the progression of
coronary atherosclerosis to recurrent ACS and mortality. It may ultimately inform the
development and testing of novel primary and secondary prevention strategies, improve
extant primary and secondary prevention strategies, and result in superior patient
management. Indeed, a staggering number of American adults have CHD and remain at
considerable risk for cardiovascular deterioration and recurrent ACS events. Although
traditional conceptual models and research strategies have offset this risk somewhat, newer
models and corresponding programs of research such as the Perfect Storm are urgently
needed if progress is to continue.
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ACS Acute Coronary Syndrome
BTG β Thromboglobulin
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MSI Mental Stress Provoked Myocardial Ischemia
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A Perfect Storm Model of Depression and Post-ACS Recurrence/Mortality Risk
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Long Axis Myocardial Perfusion Image (MPI) demonstrating a new inferior/anterior
myocardial perfusion defect with mental stress
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